Shanghai RAAS Blood Products Co., Ltd., together with its subsidiaries, produces and sells blood products in China and internationally. The company offers ALBUR...
Shanghai RAAS has continuously received a Wind ESG AA rating, with a comprehensive score of 8.70
Shanghai RAAS: Executives have increased their holdings by 0.014% of shares
Shanghai RAAS: The net profit for the third quarter was 441 million yuan, a decrease of 26.16%
Shanghai RAAS's controlling shareholder Haiyingkang has completed an increase in holdings, with a total investment amount of approximately 500 million yuan
Shanghai RAAS: Executives plan to increase holdings by 6 million yuan
Shanghai RAAS: Cumulatively repurchased 1.03% of the company's shares